| Silver nanoparticles: synthesis, properties, and therapeutic applications L Wei, J Lu, H Xu, A Patel, ZS Chen, G Chen Drug discovery today 20 (5), 595-601, 2015 | 1018 | 2015 |
| Multidrug resistance associated proteins in multidrug resistance K Sodani, A Patel, RJ Kathawala, ZS Chen Chinese journal of cancer 31 (2), 58, 2012 | 324 | 2012 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 203 | 2019 |
| Role of ABC transporters in cancer chemotherapy YL Sun, A Patel, P Kumar, ZS Chen Chinese journal of cancer 31 (2), 51, 2012 | 190 | 2012 |
| Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models AK Tiwari, K Sodani, C Dai, AH Abuznait, S Singh, ZJ Xiao, A Patel, ... Cancer letters 328 (2), 307-317, 2013 | 127 | 2013 |
| Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance N Anreddy, P Gupta, RJ Kathawala, A Patel, JND Wurpel, ZS Chen Molecules 19 (9), 13848-13877, 2014 | 117 | 2014 |
| Roles of sildenafil in enhancing drug sensitivity in cancer Z Shi, AK Tiwari, AS Patel, LW Fu, ZS Chen Cancer research 71 (11), 3735-3738, 2011 | 73 | 2011 |
| In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1 H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, ... British journal of pharmacology 171 (24), 5845-5857, 2014 | 65 | 2014 |
| GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2-and ABCB1-mediated drug resistance K Sodani, AK Tiwari, S Singh, A Patel, ZJ Xiao, JJ Chen, YL Sun, ... Biochemical pharmacology 83 (12), 1613-1622, 2012 | 62 | 2012 |
| Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1 YJ Wang, RJ Kathawala, YK Zhang, A Patel, P Kumar, S Shukla, KL Fung, ... Biochemical pharmacology 90 (4), 367-378, 2014 | 61 | 2014 |
| Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo K Sodani, A Patel, N Anreddy, S Singh, DH Yang, RJ Kathawala, P Kumar, ... Biochemical pharmacology 89 (1), 52-61, 2014 | 58 | 2014 |
| PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells A Patel, AK Tiwari, EE Chufan, K Sodani, N Anreddy, S Singh, ... Cancer chemotherapy and pharmacology 72, 189-199, 2013 | 58 | 2013 |
| Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar YL Sun, JJ Chen, P Kumar, K Chen, K Sodani, A Patel, YL Chen, ... PloS one 8 (2), e55576, 2013 | 48 | 2013 |
| Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2 DS Wang, A Patel, S Shukla, YK Zhang, YJ Wang, RJ Kathawala, ... Oncotarget 5 (12), 4529, 2014 | 46 | 2014 |
| Fluidized bed reactor for the biological treatment of ion-exchange brine containing perchlorate and nitrate A Patel, G Zuo, SG Lehman, M Badruzzaman, DA Clifford, DJ Roberts water research 42 (16), 4291-4298, 2008 | 45 | 2008 |
| (2010) A Patel, N Badhoniya, S Khadse, U Senarath, KE Agho, MJ Dibley, ... Infant and young child feeding indicators and determinants of poor feeding …, 2005 | 45 | 2005 |
| Masitinib antagonizes ATP-binding cassette subfamily C member 10–mediated Paclitaxel resistance: a preclinical study RJ Kathawala, K Sodani, K Chen, A Patel, AH Abuznait, N Anreddy, ... Molecular cancer therapeutics 13 (3), 714-723, 2014 | 44 | 2014 |
| Data modeling techniques for data warehouse A Patel, J Patel International Journal of Multidisciplinary Research 2 (2), 240-246, 2012 | 41 | 2012 |
| The BTK inhibitor ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1-and ABCC10-overexpressing cells and tumors H Zhang, A Patel, YJ Wang, YK Zhang, RJ Kathawala, LH Qiu, BA Patel, ... Molecular cancer therapeutics 16 (6), 1021-1030, 2017 | 38 | 2017 |
| AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance H Zhang, YJ Wang, YK Zhang, DS Wang, RJ Kathawala, A Patel, ... Cancer letters 350 (1-2), 61-68, 2014 | 38 | 2014 |
Zhe-Sheng ChenCollege of Pharmacy and Health Sciences, St. John's University在 stjohns.edu 的电子邮件经过验证
